Relationship and improvement strategies between drug nanocarrier characteristics and hemocompatibility:What can we learn from the literature
认领
摘要
This article discusses the various blood interactions that may occur with various types of nano drug-loading s...展开更多
This article discusses the various blood interactions that may occur with various types of nano drug-loading systems. Nanoparticles enter the blood circulation as foreign objects. On the one hand, they may cause a series of inflammatory reactions and immune reactions, resulting in the rapid elimination of immune cells and the reticuloendothelial system, affecting their durability in the blood circulation. On the other hand, the premise of the drug-carrying system to play a therapeutic role depends on whether they cause coagulation and platelet activation, the absence of hemolysis and the elimination of immune cells. For different forms of nano drug-carrying systems, we can find the characteristics, elements and coping strategies of adverse blood reactions that we can find in previous researches. These adverse reactions may include destruction of blood cells, abnormal coagulation system, abnormal effects of plasma proteins, abnormal blood cell behavior, adverse immune and inflammatory reactions, and excessive vascular stimulation. In order to provide help for future research and formulation work on the blood compatibility of nano drug carriers.收起
二级参考文献33
1 Wei Chen,Ying Wu,Mi Zheng,等.Establishing an experimental rat model of photo-dynamically-induced retinal vein occlusion using erythrosin B[J] .International Journal of Ophthalmology(English edition),2014,7(2):232-238. 被引量:7
2 蒋新国,崔景斌,方晓玲,等.药物的鼻粘膜纤毛毒性及评价方法[J] .药学学报,1995,30(11):848-853. 被引量:87
3 Li-Feng Qi,Zi-Rong Xu,Yan Li,等.In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells[J] .World Journal of Gastroenterology,2005,11(33):5136-5141. 被引量:9
4 Andrzej B HENDRICH.Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds[J] .Acta Pharmacologica Sinica,2006,27(1):27-40. 被引量:9
5 王冰,朱薇婕,曾晓丽,等.丹参冻干粉针中丹酚酸B稳定性研究[J] .中成药,2007,29(10):1479-1482. 被引量:4
6 赵原壁,邱祖民,黄佳英.Preparation and Analysis of Fe3O4 Magnetic Nanoparticles Used as Targeted-drug Carriers[J] .Chinese Journal of Chemical Engineering,2008,16(3):451-455. 被引量:40
7 Dan-Ying Zhang,Xi-Zhong Shen,Ji-Yao Wang,等.Preparation of chitosan-polyaspartic acid-5-fluorouracil nanoparticles and its anti-carcinoma effect on tumor growth in nude mice[J] .World Journal of Gastroenterology,2008,14(22):3554-3562. 被引量:11
8 Zih-rou HUANG,Shu-chiou HUA,Yueh-lung YANG,等.Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion[J] .Acta Pharmacologica Sinica,2008,29(9):1094-1102. 被引量:7
9 Mu-Fei Tang,Lei Lei,Sheng-Rong Guo,等.Recent progress in nanotechnology for cancer therapy[J] .Chinese Journal of Cancer,2010,29(9):775-780. 被引量:6
10 李文波,周晨,曹成波,等.医用聚氨酯材料研究新进展[J] .中国生物医学工程学报,2011,30(1):130-134. 被引量:13
共引文献543
1 曹丽萍,金红柳,洪晔,等.山柰酚固体分散体对α-萘异硫氰酸诱导大鼠胆汁淤积性肝损伤的影响[J] .中药材,2022,45(7):1731-1734. 被引量:6
2 Wenqi Yu,Ruyi Lin,Xueqin He,等.Self-propelled nanomotor reconstructs tumor microenvironment through synergistic hypoxia alleviation and glycolysis inhibition for promoted anti-metastasis[J] .Acta Pharmaceutica Sinica B,2021,11(9):2924-2936. 被引量:18
3 Xiaochun Wang,Imran Shair Mohammad,Lifang Fan,等.Delivery strategies of amphotericin B for invasive fungal infections[J] .Acta Pharmaceutica Sinica B,2021,11(8):2585-2604. 被引量:23
4 Yanping Huang,Qin Yu,Zhongjian Chen,等.In vitro and in vivo correlation for lipid-based formulations: Current status and future perspectives[J] .Acta Pharmaceutica Sinica B,2021,11(8):2469-2487. 被引量:10
5 Edgar Pérez-Herrero,Alberto Fernández-Medarde.The reversed intra- and extracellular pH in tumors as a unified strategy to chemotherapeutic delivery using targeted nanocarriers[J] .Acta Pharmaceutica Sinica B,2021,11(8):2243-2264. 被引量:5
6 Yanan Li,Cangang Zhang,Guo Li,等.Protease-triggered bioresponsive drug delivery for the targeted theranostics of malignancy[J] .Acta Pharmaceutica Sinica B,2021,11(8):2220-2242. 被引量:8
7 Xinyu Lou,Dong Zhang,Hao Ling,等.Pure redox-sensitive paclitaxelemaleimide prodrug nanoparticles: Endogenous albumininduced size switching and improved antitumor efficiency[J] .Acta Pharmaceutica Sinica B,2021,11(7):2048-2058. 被引量:9
8 Nitin Bharat Charbe,Nikhil D.Amnerkar,B.Ramesh,等.Small interfering RNA for cancer treatment:overcoming hurdles in delivery[J] .Acta Pharmaceutica Sinica B,2020,10(11):2075-2109. 被引量:41
9 Lingyan Zhang,Mifang Li,Quan Zhou,等.Computed tomography and photoacoustic imaging guided photodynamic therapy against breast cancer based on mesoporous platinum with insitu oxygen generation ability[J] .Acta Pharmaceutica Sinica B,2020,10(9):1719-1729. 被引量:5
10 Somayeh Mahdinloo,Seyed Hossein Kiaie,Ala Amiri,等.Efficient drug and gene delivery to liver fibrosis:rationale, recent advances, and perspectives[J] .Acta Pharmaceutica Sinica B,2020,10(7):1279-1293. 被引量:10
同被引文献227
1 Yujie Shi,An Lu,Xiangyu Wang,等.A review of existing strategies for designing long-acting parenteral formulations: Focus on underlying mechanisms, and future perspectives[J] .Acta Pharmaceutica Sinica B,2021,11(8):2396-2415. 被引量:16
2 Mingming Zhang,Shan Gao,Dongjuan Yang,等.Influencing factors and strategies of enhancing nanoparticles into tumors in vivo[J] .Acta Pharmaceutica Sinica B,2021,11(8):2265-2285. 被引量:17
3 Nicole B.Day,William C.Wixson,C.Wyatt Shields IV.Magnetic systems for cancer immunotherapy[J] .Acta Pharmaceutica Sinica B,2021,11(8):2172-2196. 被引量:11
4 Riffat Batool,Ejaz Aziz,Javed Iqbal,等.In vitro antioxidant and anti-cancer activities and phytochemical analysis of Commelina benghalensis L. root extracts[J] .Asian Pacific Journal of Tropical Biomedicine,2020,10(9):417-425. 被引量:2
5 Yue Chang,Hai Li.Hepatic Antifibrotic Pharmacotherapy:Are We Approaching Success?[J] .Journal of Clinical and Translational Hepatology,2020,8(2):222-229. 被引量:11
6 Henry Hirschberg,Kristian Berg,Qian Peng.Photodynamic therapy mediated immune therapy of brain tumors[J] .Neuroimmunology and Neuroinflammation,2018,5(7):1-11. 被引量:3
7 Vivek K.Bajpai,Ajay Sharma,Sun Chul Kang,等.Antioxidant,lipid peroxidation inhibition and free radical scavenging efficacy of a diterpenoid compound sugiol isolated from Metasequoia glyptostroboides[J] .Asian Pacific Journal of Tropical Medicine,2014,7(1):9-15. 被引量:9
8 Akuodor GC,Essien AD,David-Oku E,等.Gastroprotective effect of the aqueous leaf extract of Guiera senegalensis in Albino rats[J] .Asian Pacific Journal of Tropical Medicine,2013,6(10):771-775. 被引量:3
9 Vivek Kumar Vyas,Keyur Brahmbhatt,Hardik Bhatt,等.Therapeutic potential of snake venom in cancer therapy:current perspectives[J] .Asian Pacific Journal of Tropical Biomedicine,2013,3(2):156-162. 被引量:9
10 LiGAO,Bao-enSHAN,JingCHEN,等.Effects of spider Macrothele raven venom on cell proliferation and cytotoxicity in HeLa cells[J] .Acta Pharmacologica Sinica,2005,26(3):369-376. 被引量:18
二级引证文献66
1 罗仁幸,王妍妍,黄功华.纳米载药技术在几种常见自身免疫性疾病模型中的应用研究进展[J] .中南药学,2023,21(7):1890-1896. 被引量:2
2 刘陈霏,肖聪聪,刘艳红,等.仿生型纳米药物递送系统在神经系统疾病中的研究进展[J] .药学学报,2023,58(8):2300-2310. 被引量:4
3 覃孝平,朱盛,李跃,等.超支化疏水缔合聚合物的合成及性能[J] .化学研究与应用,2023,35(10):2503-2510. 被引量:9
4 马蓉霞,张文杰,杨晓娟,等.不同病因肝硬化患者临床特征及其预后影响因素分析[J] .现代生物医学进展,2023,23(19):3683-3689. 被引量:9
5 张昊熙昱,林龙飞,刘宇灵,等.荜茇酰胺抗肿瘤及其纳米给药系统研究进展[J] .中国中药杂志,2024,49(8):2117-2127. 被引量:4
6 Jun Zhong,Xiang Zheng,Yuan Wen,等.NIR-switchable local hydrogen generation by tandem bimetallic MOFs nanocomposites for enhanced chemodynamic therapy[J] .Regenerative Biomaterials,2024,3(1):58-68. 被引量:2
7 张为良,周鹏,李小磊,等.示踪剂米托蒽醌和纳米炭在机器人甲状腺癌手术中的应用效果比较[J] .中国普通外科杂志,2024,33(5):762-771. 被引量:8
8 王磊杰,林啟浩,林佳杰,等.积雪草苷通过调节钙信号稳态缓解肝纤维化[J] .中国细胞生物学学报,2024,46(6):1143-1158.
9 叶超,刘晓红.生物材料异物反应的调控策略[J] .中国组织工程研究,2025,29(16):3513-3520. 被引量:2
10 Xiaotong Li,Jianhua He,Wei He.Cell carriers change the in vivo fate of nanoparticles[J] .Acta Pharmaceutica Sinica B,2024,14(12):5515-5517.
1 Heng Mei,Shengsheng Cai,Dennis Huang,等.Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy:From intrinsic physicochemical properties to external modification[J] .Bioactive Materials,2022,7(2):220-240. 被引量:26
2 Jin-Rong Zheng,Mang-Mang Sang.Opportunities and challenges of nano/micro motors in biomedical applications[J] .Precision Medicine Research,2023,5(1):25-27.
3 Krystal A Hughes,Bishal Misra,Maryam Maghareh,等.Use of stimulatory responsive soft nanoparticles for intracellular drug delivery[J] .Nano Research,2023,16(5):6974-6990.
4 Zaiqian Tu,Peter Timashev,Junge Chen,等.Ferritin-based drug delivery system for tumor therapy[J] .BMEMat(BioMedical Engineering Materials),2023,1(2):1-10. 被引量:9
5 Chao Gao,Ran Xiong,Zhi-yu Zhang,等.Hybrid nanostructures for neurodegenerative disease theranostics:the art in the combination of biomembrane and non-biomembrane nanostructures[J] .Translational Neurodegeneration,2024,13(1):462-477. 被引量:1
6 Makhloufi Zoulikha,Zhongjian Chen,Jun Wu,等.Approved delivery strategies for biopharmaceuticals[J] .Chinese Chemical Letters,2025,36(2):41-51. 被引量:1
7 Jinhong Xu,Xiangyi Liao,Danli Chen,等.Microneedles for non-transdermal drug delivery:design strategies and current applications[J] .Bio-Design and Manufacturing,2025,8(2):243-274. 被引量:1
8 Teng Ma,Tuyen Ba Tran,Ethan Lin,等.Size-transformable nanotherapeutics for cancer therapy[J] .Acta Pharmaceutica Sinica B,2025,15(2):834-851.
9 Yuqian Wang,Renqi Huang,Shufan Feng,等.Advances in nanocarriers for targeted drug delivery and controlled drug release[J] .Chinese Journal of Natural Medicines,2025,23(5):513-528. 被引量:3
10 Dandan Kou,Keyang Xu,Jiahui Yin,等.Intranasal delivery of rotigotine to the brain for treating Parkinson’s disease[J] .Fundamental Research,2025,5(5):1911-1919. 被引量:1
;
使用中文期刊助手 扫描二维码